pharma · Transfusion Dependent Beta-Thalassaemia · Labor Induction
Guangzhou Virotech Pharmaceutical
Guangzhou Virotech Pharmaceutical Co.,
Guangzhou Virotech Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Transfusion Dependent Beta-Thalassaemia, Labor Induction. NovaPharmaNews links 2 clinical program(s)
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Induction of labor with PGE2
Approved · small molecule · Labor Induction
Induction of labor with PGE2 for Labor Induction is a Approved program (small_molecule) at Guangzhou Virotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code [2020]31201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Guangzhou Virotech Pharmaceutical Co.,
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Labor Induction
- Status
- on_hold
- Trials
- 1